Suppr超能文献

组蛋白去乙酰化酶作为治疗人类神经退行性疾病的靶点。

Histone deacetylases as targets for the treatment of human neurodegenerative diseases.

作者信息

D'Mello Santosh R

机构信息

Department of Molecular and Cell Biology, University of Texas, Dallas, Texas, USA.

出版信息

Drug News Perspect. 2009 Nov;22(9):513-24. doi: 10.1358/dnp.2009.9.1428871.

Abstract

Histone deacetylases (HDACs) are a family of proteins that play an important role in regulating transcription as well as the function of a variety of cellular proteins. While these proteins are expressed abundantly in the brain, little is known about their roles in brain function. A growing body of evidence suggests that HDACs regulate neuronal survival. Results from studies conducted in vertebrate and mammalian experimental systems indicate that while some of these proteins are involved in promoting neuronal death, a majority of the HDACs studied thus far protect against neurodegeneration. Here we review the research performed on the role played by individual members of the HDAC family in the regulation of neuronal death. Chemical inhibitors of HDACs have been used in a variety of models of neurodegenerative disorders. We summarize the results from these studies, which indicate that HDAC inhibitors show great promise as therapeutic agents for human neurodegenerative disorders.

摘要

组蛋白去乙酰化酶(HDACs)是一类蛋白质家族,在调节转录以及多种细胞蛋白的功能方面发挥着重要作用。虽然这些蛋白质在大脑中大量表达,但人们对它们在脑功能中的作用知之甚少。越来越多的证据表明,HDACs调节神经元存活。在脊椎动物和哺乳动物实验系统中进行的研究结果表明,虽然其中一些蛋白质参与促进神经元死亡,但迄今为止研究的大多数HDACs可预防神经退行性变。在此,我们综述了关于HDAC家族个别成员在调节神经元死亡中所起作用的研究。HDACs的化学抑制剂已被用于多种神经退行性疾病模型。我们总结了这些研究的结果,这些结果表明HDAC抑制剂作为人类神经退行性疾病的治疗药物具有巨大潜力。

相似文献

1
Histone deacetylases as targets for the treatment of human neurodegenerative diseases.
Drug News Perspect. 2009 Nov;22(9):513-24. doi: 10.1358/dnp.2009.9.1428871.
2
Multiple roles of HDAC inhibition in neurodegenerative conditions.
Trends Neurosci. 2009 Nov;32(11):591-601. doi: 10.1016/j.tins.2009.06.002. Epub 2009 Sep 21.
3
HDAC inhibitors and neurodegeneration: at the edge between protection and damage.
Pharmacol Res. 2010 Jul;62(1):11-7. doi: 10.1016/j.phrs.2010.01.011. Epub 2010 Feb 1.
4
Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
J Neuropathol Exp Neurol. 2018 Oct 1;77(10):855-870. doi: 10.1093/jnen/nly073.
5
HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
J Neurol Sci. 2011 May 15;304(1-2):1-8. doi: 10.1016/j.jns.2011.02.017. Epub 2011 Mar 5.
6
HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.
Cell Death Differ. 2006 Apr;13(4):539-50. doi: 10.1038/sj.cdd.4401769.
7
A role for histone deacetylases in the cellular and behavioral mechanisms underlying learning and memory.
Learn Mem. 2014 Sep 16;21(10):564-8. doi: 10.1101/lm.036012.114. Print 2014 Oct.
8
SIRTUIN 1: regulating the regulator.
Biochem Biophys Res Commun. 2008 Nov 14;376(2):251-5. doi: 10.1016/j.bbrc.2008.08.137. Epub 2008 Sep 5.
9
Human neuronal cells: epigenetic aspects.
Biomol Concepts. 2013 Aug;4(4):319-33. doi: 10.1515/bmc-2012-0053.
10
Therapeutic application of histone deacetylase inhibitors for stroke.
Cent Nerv Syst Agents Med Chem. 2011 Jun 1;11(2):138-49. doi: 10.2174/187152411796011330.

引用本文的文献

9
Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.
Neural Plast. 2020 Jun 5;2020:6970190. doi: 10.1155/2020/6970190. eCollection 2020.
10
The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression.
BMC Neurosci. 2019 Dec 28;20(1):65. doi: 10.1186/s12868-019-0546-0.

本文引用的文献

1
Epigenetic control of skull morphogenesis by histone deacetylase 8.
Genes Dev. 2009 Jul 15;23(14):1625-30. doi: 10.1101/gad.1809209.
2
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.
Arch Biochem Biophys. 2009 Jun 15;486(2):95-102. doi: 10.1016/j.abb.2009.01.018.
3
SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle.
Cell. 2009 May 1;137(3):560-70. doi: 10.1016/j.cell.2009.02.026.
5
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
Cancer Lett. 2009 Aug 8;280(2):125-33. doi: 10.1016/j.canlet.2009.02.042. Epub 2009 Apr 8.
6
Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway.
Neuroscience. 2009 Mar 31;159(3):993-1002. doi: 10.1016/j.neuroscience.2009.01.017. Epub 2009 Jan 19.
8
HDACi--targets beyond chromatin.
Cancer Lett. 2009 Aug 8;280(2):160-7. doi: 10.1016/j.canlet.2009.02.028. Epub 2009 Apr 1.
9
Isoform-specific histone deacetylase inhibitors: the next step?
Cancer Lett. 2009 Aug 8;280(2):211-21. doi: 10.1016/j.canlet.2009.02.013. Epub 2009 Mar 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验